GLP-1RA use necessitated shifting priorities in nutrition and lifestyle modification among patients with obesity, according ...

About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.

The panel highlighted the critical issue of how thousands of borough residents — particularly those in historically marginalized communities — struggle daily to access affordable, nutritious food.

David Kessler took GLP-1 drugs to help manage his weight. In his new book, he explains why the drugs are revolutionary, but ...

A new drug from California-based pharma company Amgen, which has concluded a phase II trial, shows promise as a powerful ...

In medically indicated weight loss, attention is typically focused on the associated health benefits. However, recent ...

For instance, survivors with cancers related to obesity often face higher risks for cancer recurrence and death—not just from ...

An investigational drug developed by Eolo Pharma is showing promise in animal experiments and an early human trial. It could ...

Clearly, obesity can lead to a host of medical problems, including diabetes, liver disease, heart disease, cancers, sleep apnea and increased mortality. This is a serious condition.

A new study revealed that fat cells retain a memory of obesity, influencing metabolism and making weight regain more likely. Experts discuss the complex factors involved.

In the study, researchers looked at electronic health record data for obese people and those with type 2 diabetes, all with no prior history of cancer, who were treated with first-generation GLP-1 ...

World Obesity Day 2025 focuses on unity to end obesity. Explore its theme, history, and how it’s driving global change for better health and well-being. Written by: Vivek Kumar ...